Help Colleagues Decipher FDA's New Med Safety in Pregnancy Ratings

October 2018

Clinicians are trying to determine the best way to evaluate med safety in pregnancy.

An FDA rule removed the letter categories...A, B, C, D, and X...for meds approved since July 2015. Older meds must remove them by 2020.

The old categories were oversimplified and often misinterpreted.

Get unlimited access through an Enterprise license

Hospital Pharmacist's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
300+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Learn More

Already a subscriber? Log in

Not sold to individuals

Table of Contents

Antibiotics Expect More Use of the Antibiotics Avycaz or Vabomere for "CRE"
Hematology & Oncology Watch for Autoimmune-Like Effects From Cancer Immunotherapy
Influenza Encourage Patients to Get Vaccinated Now for the 2018-2019 Influenza Season
Pediatrics Incorporate Specific Steps to Reduce Pediatric Med Errors
Antipsychotics Watch for Errors With Long-Acting Injectable Antipsychotics
Cardiology Suggest Screening Post-MI Patients for Depression at Follow-Up Appointments
HIV & AIDS Expect Integrase Inhibitors to Gain an Edge in Treating HIV
Pregnancy Help Colleagues Decipher FDA's New Med Safety in Pregnancy Ratings
Dermatology Get to the Bottom of Diaper Rash in Adults and Kids
Pharmacogenetics Be Aware of the Role of Pharmacogenetic Testing for Mental Health Conditions
New Drugs Stay Alert for the New Endometriosis Med, Elagolix (Orilissa)
Ensure Safe Use if Your Hospital Allows Essential Oils